Neurobehavioural effects of occupational exposure to cadmium: a cross sectional epidemiological study
- PMID: 10711265
- PMCID: PMC1739855
- DOI: 10.1136/oem.57.1.19
Neurobehavioural effects of occupational exposure to cadmium: a cross sectional epidemiological study
Abstract
Background: A patient with unexplained minor behavioural changes associated with an axonal sensorimotor polyneuropathy had a history of chronic occupational exposure to cadmium (Cd). Although animal studies have shown that Cd is a potent neurotoxicant, little is known about its toxicity for the human central nervous system. The aim of this study was to investigate the toxic potential of chronic occupational exposure to Cd on neurobehavioural functions.
Methods: A cross sectional epidemiological study was conducted ina group of Cd workers and an age matched control group. Eighty nine adult men (42 exposed to Cd and 47 control workers) were given a blinded standardised examination that consisted of computer assisted neurobehavioural tests (neurobehavioural examination system), a validated questionnaire to assess neurotoxic complaints (neurotoxicity symptom checklist--60, NSC-60), and a standardised self administered questionnaire to detect complaints consistent with peripheral neuropathy and dysfunction of the autonomic nervous system. Historical and current data on biomonitoring of exposure to Cd, either the highest value of Cd in urine (CdU in microgram Cd/g creatinine) of each Cd worker during work (CdUmax) or the current value (CdUcurrent) of each control, were available as well as data on microproteinuria.
Results: Cd workers (CdUmax: mean (range), 12.6 (0.4-38.4)) performed worse than the controls (CdUcurrent: mean (range), 0.7 (0.1-2.0)) on visuomotor tasks, symbol digit substitution (p = 0.008), and simple reaction time to direction (p = 0.058) or location (p = 0.042) of a stimulus. In multiple linear regression analysis, symbol digit substitution, simple direction reaction time test, and simple location reaction time test were significantly related to CdUmax, (beta = 0.35 (p < 0.001), beta = 0.25 (p = 0.012), and beta = 0.23 (p = 0.021) respectively). More complaints consistent with peripheral neuropathy (p = 0.004), complaints about equilibrium (p = 0.015), and complaints about concentration ability (p = 0.053) were found in the group exposed to Cd than in the control group, and these variables correlated positively with CdUmax (peripheral neuropathy: beta = 0.38, p < 0.001; equilibrium: beta = 0.22, p = 0.057; concentration ability: beta = 0.27, p = 0.020).
Conclusion: Slowing of visuomotor functioning on neurobehavioural testing and increase in complaints consistent with peripheral neuropathy, complaints about equilibrium, and complaints about concentration ability were dose dependently associated with CdU. Age, exposure to other neurotoxicants, or status of renal function could not explain these findings. The present study also indicates that an excess of complaints may be detected in Cd workers before signs of microproteinuria induced by Cd occur.
Similar articles
-
Cadmium: a possible etiological factor in peripheral polyneuropathy.Neurotoxicology. 1999 Feb;20(1):7-16. Neurotoxicology. 1999. PMID: 10091854 Clinical Trial.
-
Neurobehavioural changes and persistence of complaints in workers exposed to styrene in a polyester boat building plant: influence of exposure characteristics and microsomal epoxide hydrolase phenotype.Occup Environ Med. 2001 Feb;58(2):103-12. doi: 10.1136/oem.58.2.103. Occup Environ Med. 2001. PMID: 11160988 Free PMC article.
-
Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity.Ren Fail. 1999 May-Jul;21(3-4):251-62. doi: 10.3109/08860229909085087. Ren Fail. 1999. PMID: 10416202 Review.
-
Reversibility of microproteinuria in cadmium workers with incipient tubular dysfunction after reduction of exposure.Am J Ind Med. 1997 May;31(5):645-52. doi: 10.1002/(sici)1097-0274(199705)31:5<645::aid-ajim21>3.0.co;2-y. Am J Ind Med. 1997. PMID: 9099369
-
[Cadmium toxicity: summary of personal studies].Toxicol Eur Res. 1982 Jan;4(1):7-17. Toxicol Eur Res. 1982. PMID: 7051422 Review. French.
Cited by
-
Mechanisms of Phytoremediation by Resveratrol against Cadmium Toxicity.Antioxidants (Basel). 2024 Jun 27;13(7):782. doi: 10.3390/antiox13070782. Antioxidants (Basel). 2024. PMID: 39061851 Free PMC article. Review.
-
Role of SIRT1 in Potentially Toxic Trace Elements (Lead, Fluoride, Aluminum and Cadmium) Associated Neurodevelopmental Toxicity.Biol Trace Elem Res. 2024 Feb 28. doi: 10.1007/s12011-024-04116-5. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 38416341 Review.
-
Egg White Hydrolysate Mitigates Cadmium-induced Neurological Disorders and Oxidative Damage.Neurochem Res. 2024 Jun;49(6):1603-1615. doi: 10.1007/s11064-024-04110-2. Epub 2024 Feb 14. Neurochem Res. 2024. PMID: 38353895 Free PMC article.
-
Moderate selenium mitigates hand grip strength impairment associated with elevated blood cadmium and lead levels in middle-aged and elderly individuals: insights from NHANES 2011-2014.Front Pharmacol. 2023 Dec 14;14:1324583. doi: 10.3389/fphar.2023.1324583. eCollection 2023. Front Pharmacol. 2023. PMID: 38161700 Free PMC article.
-
Mechanisms of Cadmium Neurotoxicity.Int J Mol Sci. 2023 Nov 21;24(23):16558. doi: 10.3390/ijms242316558. Int J Mol Sci. 2023. PMID: 38068881 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical